您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > β-NETA
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
β-NETA
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
β-NETA图片
CAS NO:31059-54-8
包装与价格:
包装价格(元)
5 mg电议
10 mg电议
25 mg电议
50 mg电议
100 mg电议
200 mg电议
500 mg电议
1 mL*10 mM(in DMSO)电议

产品名称
α-NETA
产品介绍
β-NETA 是胆碱乙酰转移酶 (ChA;IC50=76 μM) 和胆碱酯酶 (ChE;IC50=40 μM)的非竞争性抑制剂,对乙酰胆碱酯的作用微弱 (AChE;IC50=1 mM)。

产品描述

α-NETA is a stable, noncompetitive, slowly reversible choline acetyltransferase (ChAT) inhibitor with an IC50 of 9 μM and is a potent chemokine-like receptor-1 (CMKLR1) antagonist. α-NETA has anti-cancer activity[1][2]. α-NETA weakly inhibits cholinesterase (IC50=84 μM) and acetylcholinesterase (IC50=300 μM).

体外活性

a-NETA treatment increases EOC cell expression of pyroptosis-associated proteins[3]. a-NETA (50-150 nM; 24 hours) decreases all cell lines viability in a dose-dependent manner [3]. a-NETA (2.5-10.0 μg/mL; 24 hours) leads to epithelial ovarian cancer (EOC) cell death associated with membrane blistering and cytoplasm leakage[3].

体内活性

a-NETA (s.c. injection; 3 mg/kg or 10 mg/kg; daily; for 30 days) significantly delays the onset of EAE with 3 mg/kg, and completely suppresses clinical signs for an average of nine days with 10 mg/kg beyond the first appearance of disease in control female C57BL/6 mice[2]. a-NETA (injected intraperitoneally; 0.125 mg/kg; once every other day for 20 days) significantly decreases tumor volume and tumor weight[3].

Cas No.

31059-54-8

分子式

C16H20INO

分子量

369.24

别名

α-NETA

储存和溶解度

DMSO:31.25 mg/mL (84.63 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years